Chandra Smita, Chandra Harish, Sindhwani Girish
Department of Pathology, Himalayan Institute of Medical Sciences, Doiwala, Dehradun, Uttarakhand, India.
Department of Pulmonary Medicine, Himalayan Institute of Medical Sciences, Doiwala, Dehradun, Uttarakhand, India.
J Cytol. 2014 Oct-Dec;31(4):189-93. doi: 10.4103/0970-9371.151128.
This study was conducted to assess the role of cytology in the diagnosis of lung lesions and to compare it with histopathology. It was also intended to evaluate the role of rapid on site evaluation (ROSE) as an adjunct to cytological diagnosis of lung lesions.
The study included all the cases of lung lesions, which were diagnosed on cytology followed by histopathology over a period of 2½ years along with ROSE, wherever possible.
Cytology was done in total 782 cases of various lung lesions and of this cyto-histopathological correlation was available in 215 cases. ROSE was done in 93.4% of total cases and smears were considered on the site adequate in the first pass in 68.1% cases and in second pass adequacy increased to 93.4%. The diagnostic accuracy of cytology was 75.3%, and that of histology was 86.9% in the diagnosis of lung lesions. The diagnostic accuracy of cytology for squamous cell carcinoma (94.4%) and adenocarcinoma (96.5%) was higher than that of histology.
Cytology is comparable to histology in the diagnosis of lung lesions and may even outperform biopsy in lung tumor diagnosis. The advantages of cytology may be further added by better sampling and preanalytical assessment for adequate diagnostic material and ROSE has proved to be an important, easy and cost effective adjunct in this regard. A multidisciplinary approach involving pulmonologist, radiologist and cytopathologist with ROSE, followed by vigilant morphological examination may increase diagnostic utility of cytology for lung lesions.
本研究旨在评估细胞学在肺部病变诊断中的作用,并将其与组织病理学进行比较。同时,还旨在评估快速现场评估(ROSE)作为肺部病变细胞学诊断辅助手段的作用。
该研究纳入了所有肺部病变病例,这些病例在2年半的时间里先经细胞学诊断,随后进行组织病理学诊断,且尽可能进行ROSE。
共对782例各种肺部病变进行了细胞学检查,其中215例有细胞-组织病理学相关性。93.4%的病例进行了ROSE,68.1%的病例涂片在首次检查时被认为现场足够,第二次检查时足够率增至93.4%。在肺部病变诊断中,细胞学的诊断准确率为75.3%,组织学的诊断准确率为86.9%。细胞学对鳞状细胞癌(94.4%)和腺癌(96.5%)的诊断准确率高于组织学。
在肺部病变诊断中,细胞学与组织病理学相当,甚至在肺部肿瘤诊断中可能优于活检。通过更好地采样和对足够诊断材料进行分析前评估,可进一步增加细胞学的优势,并且ROSE已被证明在这方面是一种重要、简便且具有成本效益的辅助手段。涉及肺科医生、放射科医生和细胞病理学家并采用ROSE,随后进行细致的形态学检查的多学科方法,可能会提高细胞学对肺部病变的诊断效用。